SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950142-10-000405
Filing Date
2010-03-10
Accepted
2010-03-10 18:53:16
Documents
2
Period of Report
2010-03-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4_sfmpart030810-mapex.html 4  
1 FORM 4 form4_sfmpart030810-mapex.xml 4 8069
2 EXHIBIT 99.1 ex99-1_sfmpart.htm EX-99 1563
  Complete submission text file 0000950142-10-000405.txt   12244
Mailing Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106
Business Address C/O SOROS FUND MANAGEMENT LLC 888 SEVENTH AVENUE 31ST FLOOR NEW YORK NY 10106 212 262 6300
SFM AH LLC (Reporting) CIK: 0001237655 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33719 | Film No.: 10671889

Mailing Address C/O SOROS FUND MANAGEMENT LLC 888 SEVENTH AVE 31ST FLOOR NEW YORK NY 10106
Business Address C/O SOROS FUND MANAGEMENT LLC 888 SEVENTH AVE 31ST FLOOR NEW YORK NY 10106 (212) 651-6389
SFM PARTICIPATION LP (Reporting) CIK: 0001253598 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33719 | Film No.: 10671890

Mailing Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043
Business Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043 650-386-3100
MAP Pharmaceuticals, Inc. (Issuer) CIK: 0001401923 (see all company filings)

IRS No.: 200507047 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations